<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>55(4)</volume><submitter>Ryan AL</submitter><pubmed_abstract>Influenza vaccination is recommended for children following allogeneic haematopoietic stem cell transplant (HSCT), however there is limited evidence regarding its benefit. A prospective multicentre study was conducted to evaluate the immunogenicity of the inactivated influenza vaccine in children who have undergone HSCT compared with healthy age-matched controls. Participants were vaccinated between 2013 and 2016 according to Australian guidelines. Influenza-specific hemagglutinin inhibition antibody titres were performed prior to each vaccination and 4 weeks following the final vaccination. A nasopharyngeal aspirate for influenza was performed on participants that developed influenza-like illness. There were 86 children recruited; 43 who had undergone HSCT and 43 controls. For the HSCT gr</pubmed_abstract><journal>Bone marrow transplantation</journal><pagination>773-779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7223911</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.</pubmed_title><pmcid>PMC7223911</pmcid><pubmed_authors>Kerr F</pubmed_authors><pubmed_authors>Richmond PC</pubmed_authors><pubmed_authors>Carolan LA</pubmed_authors><pubmed_authors>Barr IG</pubmed_authors><pubmed_authors>Wadia UD</pubmed_authors><pubmed_authors>Blyth CC</pubmed_authors><pubmed_authors>Jacoby P</pubmed_authors><pubmed_authors>Laurie KL</pubmed_authors><pubmed_authors>Fraser C</pubmed_authors><pubmed_authors>Mechinaud F</pubmed_authors><pubmed_authors>Cheung LC</pubmed_authors><pubmed_authors>Ryan AL</pubmed_authors><pubmed_authors>Tapp H</pubmed_authors><pubmed_authors>Kotecha RS</pubmed_authors><pubmed_authors>Gottardo NG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.</name><description>Influenza vaccination is recommended for children following allogeneic haematopoietic stem cell transplant (HSCT), however there is limited evidence regarding its benefit. A prospective multicentre study was conducted to evaluate the immunogenicity of the inactivated influenza vaccine in children who have undergone HSCT compared with healthy age-matched controls. Participants were vaccinated between 2013 and 2016 according to Australian guidelines. Influenza-specific hemagglutinin inhibition antibody titres were performed prior to each vaccination and 4 weeks following the final vaccination. A nasopharyngeal aspirate for influenza was performed on participants that developed influenza-like illness. There were 86 children recruited; 43 who had undergone HSCT and 43 controls. For the HSCT gr</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Apr</publication><modification>2025-04-19T01:47:15.332Z</modification><creation>2020-05-22T20:14:53Z</creation></dates><accession>S-EPMC7223911</accession><cross_references><pubmed>31659236</pubmed><doi>10.1038/s41409-019-0728-5</doi></cross_references></HashMap>